Regulation of Survival Motor Neuron Gene Expression by Calcium Signaling
Authors:
- Kwangman ChoiKCKwangman Choi
- Ansook YangAYAnsook Yang
- Jiyeon BaekJBJiyeon Baek
- Hyejeong JeongHJHyejeong Jeong
- Yura KangYKYura Kang
- Woosun BaekWBWoosun Baek
- Joon-Chul KimJKJoon-Chul Kim
- Mingu KangMKMingu Kang
- Miri ChoiMCMiri Choi
- Youngwook HamYHYoungwook Ham
- Min-Jeong SonMSMin-Jeong Son
- Sang-Bae HanSang-Bae Han
Open Access
- 23 September 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (19) , 10234
Abstract
Spinal muscular atrophy (SMA) is caused by homozygous survival of motor neurons 1 (SMN1) gene deletion, leaving a duplicate gene, SMN2, as the sole source of SMN protein. However, a defect in SMN2 splicing, involving exon 7 skipping, results in a low level of functional SMN protein. Therefore, the upregulation of SMN protein expression from the SMN2 gene is generally considered to be one of the best therapeutic strategies to treat SMA. Most of the SMA drug discovery is based on synthetic compounds, and very few natural compounds have been explored thus far. Here, we performed an unbiased mechanism-independent and image-based screen of a library of microbial metabolites in SMA fibroblasts using an SMN-specific immunoassay. In doing so, we identified brefeldin A (BFA), a well-known inhibitor of ER-Golgi protein trafficking, as a strong inducer of SMN protein. The profound increase in SMN protein was attributed to, in part, the rescue of the SMN2 pre-mRNA splicing defect. Intriguingly, BFA increased the intracellular calcium concentration, and the BFA-induced exon 7 inclusion of SMN2 splicing, was abrogated by the depletion of intracellular calcium and by the pharmacological inhibition of calcium/calmodulin-dependent kinases (CaMKs). Moreover, BFA considerably reduced the expression of Tra2-β and SRSF9 proteins in SMA fibroblasts and enhanced the binding of PSF and hnRNP M to an exonic splicing enhancer (ESE) of exon 7. Together, our results demonstrate a significant role for calcium and its signaling on the regulation of SMN splicing, probably through modulating the expression/activity of splicing factors.Keywords
Funding Information
- National Research Foundation of Korea (2017R1E1A1A01074504, 2019R1A2C1089145, 2020R1A2C2012347)
- National Cancer Center (NCC-2010273, NCC-2010320)
- Korea Research Institute of Bioscience and Biotechnology (KGM5522113, KGS1082113, KGS1432113)
This publication has 61 references indexed in Scilit:
- Nuclear Matrix Factor hnRNP U/SAF-A Exerts a Global Control of Alternative Splicing by Regulating U2 snRNP MaturationMolecular Cell, 2012
- A screen for regulators of survival of motor neuron protein levelsNature Chemical Biology, 2011
- Endoplasmic-Reticulum Calcium Depletion and DiseaseCold Spring Harbor Perspectives in Biology, 2011
- A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severityGenes & Development, 2010
- ER–Golgi network—A future target for anti-cancer therapyLeukemia Research, 2009
- Induced pluripotent stem cells from a spinal muscular atrophy patientNature, 2008
- The SR protein family of splicing factors: master regulators of gene expressionBiochemical Journal, 2008
- SMN Deficiency Causes Tissue-Specific Perturbations in the Repertoire of snRNAs and Widespread Defects in SplicingCell, 2008
- NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphomaBlood, 2007
- Ribonucleoprotein Assembly Defects Correlate with Spinal Muscular Atrophy Severity and Preferentially Affect a Subset of Spliceosomal snRNPsPLOS ONE, 2007